FromLumistry ([email protected])
Sent withHubSpot
Subject (49)Med intel w/ Michelle: Q1 FDA approvals & updates
Preheader (150)From GLP-1 expansion to compounded medication crackdowns, here’s what's new—and what it means for your workflow. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Typography
Arial
Colors
Text Analysis
Body Words196
Subject Words9
Body Emojis3
Subject Emojis
Media Analysis
Text Links5
Image Links3
Total Links8
Images4
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px2171 px
X-Spam Score-0.2
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning

Med intel w/ Michelle: Q1 FDA approvals & updates

From GLP-1 expansion to compounded medication crackdowns, here’s what's new—and what it means for your workflow. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Med intel w/ Michelle: Q1 FDA approvals & updates